Finoriq research workspace
Altimmune, Inc. (ALT) SEC Filings & Filing Highlights
Review SEC filings, SEC-derived company events, filing highlights, source excerpts, and material disclosure activity for Altimmune, Inc. (ALT).
Company Snapshot
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
- Company
- Altimmune, Inc. (ALT)
- Ticker
- ALT
- Market Cap
- $548.4M
- Latest Price
- $2.82
- Industry
- Biotech & Pharma
Altimmune, Inc. (ALT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Altimmune, Inc. (ALT).
| Event | Form | Date |
|---|---|---|
| Cautionary Note Regarding Forward Looking StatementsOn June 16, 2026, Altimmune, Inc. (the “Company”) announced plans to relocate its corporate headquarters from Gaithersburg, Maryland to Mor... | 8-K8.01 | 2026-06-16 |
| Altimmune Announces First Quarter 2026 Financial Results and Business UpdateAltimmune Announces First Quarter 2026 Financial Results and Business Update | 8-K2.02 | 2026-05-13 |
| Altimmune, Inc.: Material agreementOn April 22, 2026, Altimmune, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partn... | 8-K1.01 | 2026-04-24 |
| On April 16, 2026, Altimmune, Inc. held its 2026 Annual Meeting of Stockholders. As of March 13...On April 16, 2026, Altimmune, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). As of March 13... | 8-K5.07 | 2026-04-16 |
| Amendment to Article of Incorporation or Bylaws; Change in Fiscal YearAmendment to Article of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-04-16 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.